Margarida Mota

Margarida Mota

Auto-generated profile, based on publicly available information

Margarida Mota

Internal Medicine, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, PRT

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in Journal of Autoimmunity
Verified
Journal Article
Closed access
DMDaniela Martins-Mendes
Daniela Martins-Mendes
MCMargarida Correia
Margarida Correia
MBMarta Barbedo
Marta Barbedo
TVTeresa Vaio
Teresa Vaio
MMMargarida Mota
Margarida Mota
JVJoão Valente
João Valente

13 November 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
MGMargarida Guerra
Margarida Guerra
ALAgostinho Lira
Agostinho Lira
ALAngelina Lameirão
Angelina Lameirão
ASAurélia Selaru
Aurélia Selaru
GAGabriela Abreu
Gabriela Abreu
Ângela NovaisÂngela Novais
Ângela Novais
Carbapenem resistance rates increased exponentially between 2014 and 2017 in Portugal (~80%), especially in Klebsiella pneumoniae. We characterized the population of carbapanemase-producing Enterobacterales (CPE) infecting or colonizing hospitalized patients (2017–2018) in a central hospital from northern Portugal, where KPC-3-producing K. pneumoniae capsular type K64 has caused an initial outbreak. We gathered phenotypic (susceptibility data), molecular (population structure, carbapenemase, capsular type) and biochemical (FT-IR) data, together with patients’ clinical and epidemiological information. A high diversity of Enterobacterales species, clones (including E. coli ST131) and carbapenemases (mainly KPC-3 but also OXA-48 and VIM) was identified three years after the onset of carbapenemases spread in the hospital studied. ST147-K64 K. pneumoniae, the initial outbreak clone, is still predominant though other high-risk clones have emerged (e.g., ST307, ST392, ST22), some of them with pandrug resistance profiles. Rectal carriage, previous hospitalization or antibiotherapy were presumptively identified as risk factors for subsequent infection. In addition, our previously described Fourier Transform infrared (FT-IR) spectroscopy method typed 94% of K. pneumoniae isolates with high accuracy (98%), and allowed to identify previously circulating clones. This work highlights an increasing diversity of CPE infecting or colonizing patients in Portugal, despite the infection control measures applied, and the need to improve the accuracy and speed of bacterial strain typing, a goal that can be met by simple and cost-effective FT-IR based typing.

18 February 2015 in Cardiovascular Drugs and Therapy
Verified
Journal Article
Closed access
PDF file
RFRicardo Fontes-Carvalho
Ricardo Fontes-Carvalho
JMJennifer Mancio
Jennifer Mancio
AMAcúrcio Marcos
Acúrcio Marcos
FSFrancisco Sampaio
Francisco Sampaio
MMMargarida Mota
Margarida Mota
AMAdelino Leite Moreira
Adelino Leite Moreira

1 January 2015 in Revista Española de Enfermedades Digestivas
Verified
Journal Article
Open access
APAna Ponte
Ana Ponte
RPRolando Pinho
Rolando Pinho
MMMargarida Mota
Margarida Mota
JSJoana Silva
Joana Silva
NVNuno Vieira
Nuno Vieira
JCJoão Carvalho
João Carvalho
Clostridium difficile infection (CDI) constitutes an important cause of antibiotic-associated diarrhea. Recurrence after first-line treatment with antibiotics is high and fecal microbiota transplantation (FMT) may be effective for refractory and recurrent CDI. This series aims to describe the efficacy of FMT in the treatment of refractory and recurrent CDI. A prospectively recorded single-centre case series of patients with persistent or recurrent CDI treated with FMT between June 2014 and March 2015 was analyzed. Primary and secondary outcomes were defined as resolution of diarrhea without recurrence of CDI within 2 months after one or more FMT, respectively. A descriptive analysis was performed. 8 FMT were performed in 6 patients, 3 with refractory CDI and 3 with recurrent CDI. The median age of recipients was 71 years and 66.7% were women. One FMT was delivered through colonoscopy and the remaining 87.5% through esophagogastroduodenoscopy. One upper FMT was excluded due to recurrence of CDI after antibiotic exposure for a respiratory infection. The overall cure rate of FMT was total with lower route and 83.3% with upper route. Primary cure rate was achieved in 83.3% of patients and secondary cure rate was achieved in all patients. Median time to resolution of diarrhea after FMT was 1 day and no complications were reported during follow-up. FMT appears to constitute a safe and effective approach in the management of refractory and recurrent CDI. Difference between primary and secondary cure rates may result of insufficient restoration of intestinal microbiota with a single FMT.

1 January 2017 in IDCases
Verified
Journal Article
Open access
FDFilipa Duarte-Ribeiro
Filipa Duarte-Ribeiro
CDCátia Dias
Cátia Dias
MMMargarida Mota
Margarida Mota
We present a 37-year-old man intravenous drug user, with HIV/HCV/HBV co-infection, lymph node tuberculosis 10 years before (completed 12 months of treatment), and left lobar pneumonia 4 years earlier complicated by empyema (treated with left lower lobectomy with a persistent bronchopleural fistula) who was admitted to the emergency department with caseous-purulent drainage and exteriorization of air from an orifice in the chest wall. Acid-fast bacilli were identified in this drainage. A pleurocutaneous fistula was evident on the chest computed tomography scan. He was admitted to the Infectious Diseases Unit and started on antituberculous therapy with a favorable outcome.

13 August 2018 in IDCases
Verified
Journal Article
Open access
PDF file
CDCátia Dias
Cátia Dias
SPSara Pipa
Sara Pipa
FDFilipa Duarte-Ribeiro
Filipa Duarte-Ribeiro
MMMargarida Mota
Margarida Mota
Multiresistant microorganism infection often can produce a life-threatening situation. We report two cases in which fecal microbiota transplantation used for the treatment of recurrent Clostridium difficile infection were effective in eradicating colonization by carbapenemase-producing Enterobacteriaceae. The presented cases illustrate the potential benefit of fecal microbiota transplantation in resolution of asymptomatic carrier states of multiresistant microorganisms, suggesting the need for further investigations with a view to their applicability in this area.